Is TCRX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for TScan Therapeutics, Inc. 10 years ago, but if you had invested on Friday 16th of July 2021 when the price was $10.50, you would have made a loss of $-4.94 per share or -47.05%
Yes, the average daily trading liquidity for TScan Therapeutics, Inc. is $2.12 million. You should therefore be able to get in and out of your positions relatively fast.
TScan Therapeutics, Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for TScan Therapeutics, Inc. to be high [0.85 out of 1]